Becton Dickinson and Company (BDX) Shares are Up 0.13%

On a relative basis, the stock has outperformed the S&P 500 by 1.91% in the past 4 weeks, but has underperformed the S&P 500 in the past 1 week. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 0.13% in the last 1 week, and is up 1.36% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

The stock has recorded a 20-day Moving Average of 1.9% and the 50-Day Moving Average is 2.7%.The 200 Day SMA reached 12.18%


Becton Dickinson and Company (NYSE:BDX): After opening at $177.02, the stock dipped to an intraday low of $177.02 on Friday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $180.575 and the buying power remained strong till the end. The stock closed at $179.73 for the day, a gain of 1.86% for the day session. The total traded volume was 1,156,117. The stocks close on the previous trading day was $179.73.

Becton Dickinson and Company (BDX) : 12 investment research analysts covering Becton Dickinson and Company (BDX) have an average price target of $185 for the near short term. The highest target price given by the Brokerage Firm to the stock is $200 and the lowest target is $169 for the short term. Analysts expect the variance to be within $9.29 of the average price.

Becton, Dickinson and Company is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, life science researchers, clinical laboratories, pharmaceutical industry and the general public. The Company operates through two segments: BD Medical and BD Life Sciences. The Companys Life Sciences segment consists of the BD Diagnostics and BD Biosciences segments. The Companys BD Medical segment focuses on providing solutions to reduce the spread of infection, enhance diabetes treatment and advance drug delivery. The Companys BD Diagnostics provides products for the safe collection and transport of diagnostics specimens, as well as instruments and reagent systems. Its BD Biosciences provide diagnostic and research tools to life science researchers, clinical researchers, laboratory professionals and clinicians.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.